Eligibility (Part 4 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type ...

.noscript-container { margin: 0 auto; width: 400px; text-align: center; margin-top: 150px; }

protocols.io requires JavaScript to be enabled in the browser.